AI Offers New Pathways to Strengthen Site Leadership in Underserved Regions
Artificial intelligence can help identify key opinion leaders in emerging markets to improve site influence, patient engagement, and trial success.
Gen Li, PhD, MBA, president of Phesi, discussed results from the company's analysis on global inequity in breast cancer development in a recent video interview with Applied Clinical Trials.
He highlighted the geographic concentration of breast cancer trial leaders in the US and China, with a positive outlook on global diversity.
Li attributed operational barriers in lower-income countries to traditional business models, but saw opportunities to implement a more patient-centric approach by leveraging AI and machine learning.
- Lack of local key opinion leaders in underserved areas can be addressed by identifying local leaders.
- AI can help redistribute trial workloads and improve recruitment by identifying and activating new sites.
Author's summary: AI helps identify key leaders in emerging markets.
More News
- Florence + The Machine - Everybody Scream Review
- 'Thief VR: Legacy of Shadow' Comes to All Major VR Headsets in December, New Gameplay Here
- AUS vs IND: Shivam Dube and Jasprit Bumrah’s Unbeaten T20I Streak Ends News24 -
- 13 of the Most Haunted Places in New Orleans
- MEG takeover vote postponed again over questions about Cenovus-Strathcona side deal
- Sweater Weather: Billboard Crossword (Oct. 30, 2025)
- How Samsung And NVIDIA Are Partnering To Build A Megafactory - TechRound
- JD Vance and Erika Kirk’s on-stage hug goes viral amid faith and controversy debate | The Express Tribune
- 'Hotel Transylvania' spinoff 'Motel Transylvania' delayed, now set for 2027 release on Netflix | The Express Tribune
- Upcoming Events: your complete list of Halloween happenings